Marco E. Bianchi
Impact in
- Clinical Biochemistry top 0.01%
- Advanced Glycation End Products research
- Immunology top 0.05%
- Immune Response and Inflammation
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Genomics and Chromatin Dynamics 31
- RNA Research and Splicing 21
- RNA and protein synthesis mechanisms 20
- S100 Proteins and Annexins 17
-
- Advanced Glycation End Products research 90
- Co-authors
- Paola Scaffidi (7 shared papers)Tom Misteli (1 shared paper)Angelo A. Manfredi (24 shared papers)A Agresti (25 shared papers)Mônica Beltrame (15 shared papers)Emilie Vénéreau (14 shared papers)Patrizia Rovere‐Querini (17 shared papers)Susanne Müller (9 shared papers)
- Journals
- The EMBO Journal (13 papers)Frontiers in Immunology (9 papers)Journal of Leukocyte Biology (8 papers)PLoS ONE (7 papers)Journal of Biological Chemistry (7 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Marco E. Bianchi
226 papers receiving 32.1k citations
Marco E. Bianchi's Hit Papers
Peers
Comparison fields: 5 of 166
- Clinical Biochemistry 10.9k
- Immunology 10.9k
- Neurology 2.0k
- Molecular Biology 12.9k
- Cancer Research 1.8k
Countries citing papers authored by Marco E. Bianchi
This map shows the geographic impact of Marco E. Bianchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco E. Bianchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco E. Bianchi more than expected).
Fields of papers citing papers by Marco E. Bianchi
This network shows the impact of papers produced by Marco E. Bianchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco E. Bianchi. The network helps show where Marco E. Bianchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Marco E. Bianchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 229 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Hit paper breakdown → | 2002 | 3542 |
| 2 | DAMPs, PAMPs and alarmins: all we need to know about danger Hit paper breakdown → | 2006 | 2301 |
| 3 | Endogenous HMGB1 regulates autophagy Hit paper breakdown → | 2010 | 809 |
| 4 | The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway Hit paper breakdown → | 2002 | 783 |
| 5 | Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures Hit paper breakdown → | 2010 | 774 |
| 6 | Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release Hit paper breakdown → | 2012 | 584 |
| 7 | HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses Hit paper breakdown → | 2009 | 572 |
| 8 | Specific Recognition of Cruciform DNA by Nuclear Protein HMG1 Hit paper breakdown → | 1989 | 548 |
| 9 | High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart Hit paper breakdown → | 2008 | 541 |
| 10 | HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 Hit paper breakdown → | 2012 | 530 |
| 11 | High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity Hit paper breakdown → | 2007 | 519 |
| 12 | DAMPs from Cell Death to New Life Hit paper breakdown → | 2015 | 518 |
| 13 | HMGB1 is an endogenous immune adjuvant released by necrotic cells Hit paper breakdown → | 2004 | 513 |
| 14 | Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities Hit paper breakdown → | 2007 | 503 |
| 15 | 2008 | 482 | |
| 16 | 2005 | 453 | |
| 17 | 2014 | 449 | |
| 18 | 2008 | 443 | |
| 19 | 1999 | 438 | |
| 20 | 2005 | 419 |
About Marco E. Bianchi
Marco E. Bianchi is a scholar working on Molecular Biology, Clinical Biochemistry, Immunology, Genetics and Cancer Research, having authored 229 papers that have together received 32.7k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (90 papers), Immune Response and Inflammation (47 papers), Genomics and Chromatin Dynamics (31 papers), RNA Research and Splicing (21 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (21 papers), NF-κB Signaling Pathways (21 papers), RNA and protein synthesis mechanisms (20 papers) and S100 Proteins and Annexins (17 papers). The work is most often cited by research in Clinical Biochemistry (10.9k citations), Immunology (10.9k citations), Neurology (2.0k citations), Molecular Biology (12.9k citations) and Cancer Research (1.8k citations). Marco E. Bianchi has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Paola Scaffidi, Tom Misteli, Angelo A. Manfredi, A Agresti, Mônica Beltrame, Emilie Vénéreau, Patrizia Rovere‐Querini, Susanne Müller, Lorenza Ronfani and Roberta Palumbo. Their work appears in journals such as The EMBO Journal, Frontiers in Immunology, Journal of Leukocyte Biology, PLoS ONE and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.